Published in Proc Natl Acad Sci U S A on October 01, 1991
Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med (2002) 1.58
Myosin Va and myosin VI coordinate their steps while engaged in an in vitro tug of war during cargo transport. Proc Natl Acad Sci U S A (2011) 1.23
Advanced magnetic resonance imaging of the physical processes in human glioblastoma. Cancer Res (2014) 1.16
Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by ³¹P magnetization transfer spectroscopy at 4T. Magn Reson Imaging (2012) 0.89
Measurement of creatine kinase reaction rate in human brain using magnetization transfer image-selected in vivo spectroscopy (MT-ISIS) and a volume ³¹P/¹H radiofrequency coil in a clinical 3-T MRI system. NMR Biomed (2010) 0.84
Brain high-energy phosphates and creatine kinase synthesis rate under graded isoflurane anesthesia: An in vivo (31) P magnetization transfer study at 11.7 tesla. Magn Reson Med (2014) 0.81
31P magnetic resonance spectroscopy study of the human visual cortex during stimulation in mild hypoxic hypoxia. Exp Brain Res (2008) 0.77
A branched kinetic scheme describes the mechanochemical coupling of Myosin Va processivity in response to substrate. Biophys J (2012) 0.77
Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases. J Cereb Blood Flow Metab (2017) 0.75
The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem (1956) 20.40
Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A (1986) 9.31
NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A (1982) 4.95
Cytosolic phosphorylation potential. J Biol Chem (1979) 4.90
1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol (1985) 3.91
Stimulus rate dependence of regional cerebral blood flow in human striate cortex, demonstrated by positron emission tomography. J Neurophysiol (1984) 2.87
The Pasteur effect and the relations between respiration and fermentation. Essays Biochem (1972) 2.42
Mapping human visual cortex with positron emission tomography. Nature (1986) 2.38
31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc Natl Acad Sci U S A (1977) 1.86
NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer. Q Rev Biophys (1984) 1.34
Nuclear magnetic resonance: in vivo proton chemical shift imaging. Work in progress. Radiology (1983) 1.02
Imaging of human brain creatine kinase activity in vivo. FASEB J (1989) 1.01
Fluorine-19 NMR imaging of glucose metabolism. Magn Reson Med (1988) 0.95
In vivo one-dimensional imaging of phosphorus metabolites by phosphorus-31 nuclear magnetic resonance. Science (1983) 0.93
Spatial heterogeneity of metabolism in skeletal muscle in vivo studied by 31P-NMR spectroscopy. Am J Physiol (1988) 0.92
Cerebral metabolism and patterned visual stimulation: a positron emission tomographic study of the human visual cortex. Neurology (1988) 0.89
In vivo nuclear magnetic resonance chemical shift imaging by selective irradiation. Proc Natl Acad Sci U S A (1984) 0.86
Gluconeogenesis in the perfused rat liver. Biochem J (1966) 8.58
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N Engl J Med (1981) 3.00
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia (2001) 2.97
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (1997) 2.96
Stimulus specific responses from beyond the classical receptive field: neurophysiological mechanisms for local-global comparisons in visual neurons. Annu Rev Neurosci (1985) 2.83
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med (1993) 2.59
MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology (1999) 2.58
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A (2000) 2.49
Metabolic activities of the isolated perfused rat kidney. Biochem J (1967) 2.41
Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol (2001) 2.30
Diffusion magnetic resonance imaging: its principle and applications. Anat Rec (1999) 2.26
Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol (1990) 2.24
Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology (1995) 2.20
Ultra-fast three dimensional imaging of hyperpolarized 13C in vivo. MAGMA (2005) 2.17
Hypoperfusion of Wernicke's area predicts severity of semantic deficit in acute stroke. Ann Neurol (2001) 2.09
Carbohydrate metabolism of the perfused rat liver. Biochem J (1967) 2.08
Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology (1992) 2.07
Direction- and velocity-specific responses from beyond the classical receptive field in the middle temporal visual area (MT). Perception (1985) 1.88
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
Sodium reabsorption in the perfused rat kidney. Am J Physiol (1973) 1.82
Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med (1994) 1.81
MRI measurement of brain iron in patients with restless legs syndrome. Neurology (2001) 1.75
Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med (1996) 1.72
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
Subcortical aphasia and neglect in acute stroke: the role of cortical hypoperfusion. Brain (2002) 1.70
Imaging of acute cerebral ischemia. Radiology (1999) 1.62
Enzyme distribution along the nephron. Kidney Int (1984) 1.60
Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology (1993) 1.58
Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed (2002) 1.57
Crossed cerebellar diaschisis in acute stroke detected by dynamic susceptibility contrast MR perfusion imaging. AJNR Am J Neuroradiol (2009) 1.54
Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology (1992) 1.47
Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett (2001) 1.44
Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy. Hum Gene Ther (1998) 1.43
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther (2000) 1.42
Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy. AJNR Am J Neuroradiol (2009) 1.42
Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol (2012) 1.39
31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature (1982) 1.37
Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA (2004) 1.33
Leukoencephalopathy, cerebral calcifications, and cysts: new observations. Neurology (2004) 1.33
Diffusion-negative stroke: a report of two cases. AJNR Am J Neuroradiol (2000) 1.27
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1999) 1.26
Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke (1998) 1.25
Improved function with amino acids in the isolated perfused kidney. Am J Physiol (1982) 1.23
Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med (1996) 1.21
Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke. Brain Lang (2001) 1.21
MR perfusion imaging reveals regions of hypoperfusion associated with aphasia and neglect. Neurology (2000) 1.20
Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther (1998) 1.19
A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis (2003) 1.17
Restoring blood pressure reperfused Wernicke's area and improved language. Neurology (2001) 1.14
Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem (1996) 1.14
Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med (1994) 1.13
Metabolic imaging of mild traumatic brain injury. Brain Imaging Behav (2012) 1.12
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther (2002) 1.12
Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med (2001) 1.12
Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. AJNR Am J Neuroradiol (2001) 1.10
N-acetyl aspartate--a neuronal marker? Ann Neurol (2001) 1.09
In vivo magnetic resonance imaging of hyperpolarized silicon particles. Nat Nanotechnol (2013) 1.08
Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin Cancer Res (1995) 1.07
Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci U S A (1990) 1.07
Early castration reduces prostatic carcinogenesis in transgenic mice. Urology (1999) 1.07
Effect of inhibition of gluconeogenesis on ammonia production in the perfused rat kidney. Clin Sci Mol Med (1976) 1.07
Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem (2001) 1.05
Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr (1987) 1.04
Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults? AJNR Am J Neuroradiol (2007) 1.04
The effect of experimental bile-duct obstruction on critical biosynthetic functions of the liver. Br J Surg (1972) 1.04
Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest (1995) 1.03
Mouse lemur microscopic MRI brain atlas. Neuroimage (1994) 1.03
1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed (2001) 1.03
Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med (1995) 1.03
Activation of oxoglutarate dehydrogenase in the kidney in response to acute acidosis. Biochem J (1980) 1.02
Three methods of calibration in quantitative proton MR spectroscopy. J Magn Reson B (1995) 1.02
Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke (2000) 1.01
Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn Reson Med (1995) 1.01
Childhood mitochondrial myopathy with ophthalmoplegia. J Neurol Sci (1981) 1.01
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol (1998) 1.00
Proton magnetic resonance spectroscopy of choroid plexus tumors in children. J Magn Reson Imaging (2001) 1.00
Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol (2001) 0.99
[1-13C]glucose MRS in chronic hepatic encephalopathy in man. Magn Reson Med (2001) 0.98
The importance of pH in renal preservation. Transplant Proc (1981) 0.98
A 15N-n.m.r. study of cerebral, hepatic and renal nitrogen metabolism in hyperammonaemic rats. Biochem J (1990) 0.98
Selective distal nephron damage during isolated kidney perfusion. Kidney Int (1981) 0.98
Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology (1998) 0.97
Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. AJNR Am J Neuroradiol (2001) 0.96
The isolated perfused rat kidney. Clin Sci Mol Med Suppl (1978) 0.96
Neuroimaging studies in Rett syndrome. Brain Dev (2001) 0.96
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. Gene Ther (2006) 0.96
Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res (2000) 0.96
Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke. Neuroradiology (2003) 0.95
Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA (1999) 0.95
Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. Am J Pathol (1992) 0.95
Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol (1997) 0.94
Enhancement of hyperthermia effect in vivo by amiloride and DIDS. Int J Radiat Oncol Biol Phys (1993) 0.94
Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase. Hum Gene Ther (1999) 0.94
Proton MR spectroscopy in acute middle cerebral artery stroke. AJNR Am J Neuroradiol (1996) 0.94
Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome. Pediatrics (1997) 0.94
Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med (1999) 0.93
MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology (2003) 0.93
Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol (2008) 0.93
Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy. Neurology (2005) 0.92